# A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus St

Source: https://onco.cc/trials/nct07155174/  
OnCo record `nct07155174` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of ABBV-706, Atezolizumab, Etoposide in small-cell lung cancer, run by AbbVie, now recruiting.

## Summary

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer is a phase 2 interventional study registered as NCT07155174 by AbbVie, with 180 participants planned, started 2025-11-25 and due to reach its primary completion in 2029-04. Interventions recorded: ABBV-706, Atezolizumab, Etoposide, Carboplatin, Carboplatin. Conditions listed: Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT07155174
- Phase: 2
- Setting: A Phase 2 Randomized, Open Label, Multicenter Study to Evaluate the Optimal Dose, Safety, and Efficacy of ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Subjects With Previously Untreated Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- Sponsor: AbbVie
- Enrolled: 180

## Sources

- ClinicalTrials.gov NCT07155174: https://clinicaltrials.gov/study/NCT07155174

## Connected records

- cancers: [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [ABBV-706](https://onco.cc/drugs/abbv-706/), [Atezolizumab](https://onco.cc/drugs/atezolizumab/), [Carboplatin](https://onco.cc/drugs/carboplatin/), [Etoposide](https://onco.cc/drugs/etoposide/), [Lurbinectedin](https://onco.cc/drugs/lurbinectedin/)
- companies: [AbbVie (incl. ImmunoGen, Capstan)](https://onco.cc/companies/abbvie/)

---
JSON: https://onco.cc/api/v1/entities/nct07155174.json